Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Companyโs Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Companyโs Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.
์ข
๋ชฉ ์ฝ๋ ALC
ํ์ฌ ์ด๋ฆAlcon AG
์์ฅ์ผApr 09, 2019
CEOEndicott (David J)
์ง์ ์25599
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃApr 09
์ฃผ์Rue Louis d'Affry 6
๋์FRIBOURG
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX NASDAQ Basic NYSE
๊ตญ๊ฐSwitzerland
์ฐํธ ๋ฒํธ1700
์ ํ41589113800
์น์ฌ์ดํธhttps://www.alcon.ch/
์ข
๋ชฉ ์ฝ๋ ALC
์์ฅ์ผApr 09, 2019
CEOEndicott (David J)
์ง๋ 5๋
๋์ ์ด
400.00M
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.
ALC.NB Final Cash Dividend of gross CHF 0.2 paid on May 05, 2022 going ex on Apr 29, 2022
ALC.NB Final Cash Dividend of gross CHF 0.1 paid on May 06, 2021 going ex on May 04, 2021